LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Skiba, D.S.; Nosalski, R.; Mikolajczyk, T.P.; Siedlinski, M.; Rios, F.J.; Montezano, A.C.; Jawien, J.; Olszanecki, R.; Korbut, R.; Czesnikiewicz-Guzik, M.; Touyz, R.M.; Guzik, T.J. (2017)
Publisher: Wiley
Journal: British Journal of Pharmacology
Languages: English
Types: Article
Subjects: Research Paper, Themed Section: Research Papers
Background and Purpose: \ud \ud Inflammation plays a key role in atherosclerosis. The protective role of angiotensin 1–7 (Ang-(1–7)) in vascular pathologies suggested the therapeutic use of low MW, non-peptide Ang-(1–7) mimetics, such as AVE0991. The mechanisms underlying the vaso-protective effects of AVE0991, a Mas receptor agonist, remain to be explored.\ud Experimental Approach: \ud \ud We investigated the effects of AVE0991 on the spontaneous atherosclerosis in apolipoprotein E (ApoE)−/− mice, in the context of vascular inflammation and plaque stability.\ud Key Results: \ud \ud AVE0991 has significant anti-atherosclerotic properties in ApoE−/− mice and increases plaque stability, by reducing plaque macrophage content, without effects on collagen. Using the descending aorta of chow-fed ApoE−/− mice, before significant atherosclerotic plaque develops, we gained insight to early events in atherosclerosis. Interestingly, perivascular adipose tissue (PVAT) and adventitial infiltration with macrophages and T-cells precedes atherosclerotic plaque or the impairment of endothelium-dependent NO bioavailability (a measure of endothelial function). AVE0991 inhibited perivascular inflammation, by reducing chemokine expression in PVAT and through direct actions on monocytes/macrophages inhibiting their activation, characterized by production of IL-1β, TNF-α, CCL2 and CXCL10, and differentiation to M1 phenotype. Pretreatment with AVE0991 inhibited migration of THP-1 monocytes towards supernatants of activated adipocytes (SW872). Mas receptors were expressed in PVAT and in THP-1 cells in vitro, and the anti-inflammatory effects of AVE0991 were partly Mas dependent.\ud Conclusions and Implications: \ud \ud The selective Mas receptor agonist AVE0991 exhibited anti-atherosclerotic and anti-inflammatory actions, affecting monocyte/macrophage differentiation and recruitment to the perivascular space during early stages of atherosclerosis in ApoE−/− mice.\ud Linked Articles: \ud \ud This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Ait-Oufella H, Taleb S, Mallat Z, Tedgui A (2011). Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 31: 969-979.
    • Ketelhuth DF, Hansson GK (2016). Adaptive response of T and B cells in atherosclerosis. Circ Res 118: 668-678.
    • Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010).
    • Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
    • (2014). DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest 124: 4642-4656.
    • Klein S, Herath CB, Schierwagen R, Grace J, Haltenhof T, Uschner FE et al. (2015). Hemodynamic effects of the non-peptidic angiotensin-(1-7) agonist AVE0991 in liver cirrhosis. PLoS One 10: e0138732.
    • Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA et al. (2001). Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288.
    • (2015). Effect of a selective Mas Receptor agonist in cerebral ischemia in vitro and in vivo. PLoS One 10: e0142087.
    • Libby P, Ridker PM, Hansson GK (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473: 317-325.
    • Ma Y, Huang H, Jiang J, Wu L, Lin C, Tang A et al. (2016). AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress.
    • Biochem Biophys Res Commun 474: 621-625.
    • Macritchie N, Grassia G, Sabir SR, Maddaluno M, Welsh P, Sattar N et al. (2012). Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 32: 2569-2579.
    • Magalhaes GS, Rodrigues-Machado MG, Motta-Santos D, Silva AR, Caliari MV, Prata LO et al. (2015). Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br J Pharmacol 172: 2330-2342.
    • Matusik P, Guzik B, Weber C, Guzik TJ (2012). Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb Haemost 108: 443-456.
    • McGrath JC, Lilley E (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189-3193.
    • Mikolajczyk TP, Nosalski R, Szczepaniak P, Budzyn K, Osmenda G, Skiba D et al. (2016). Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J 30: 1987-1999.
    • Oliveira-Lima OC, Pinto MC, Duchene J, Qadri F, Souza LL, Alenina N et al. (2015). Mas receptor deficiency exacerbates lipopolysaccharideinduced cerebral and systemic inflammation in mice.
    • Immunobiology 220: 1311-1321.
    • Passos-Silva DG, Verano-Braga T, Santos RA (2013). Angiotensin-(1- 7): beyond the cardio-renal actions. Clin Sci 124: 443-456.
    • Pawlik MW, Kwiecien S, Ptak-Belowska A, Pajdo R, Olszanecki R, Suski M et al. (2016). The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines. J Physiol Pharmacol 67: 75-91.
    • (2016). Chemokine RANTES is increased at early stages of coronary artery disease. J Physiol Pharmacol 67: 321-328.
    • Raffai G, Durand MJ, Lombard JH (2011). Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats. Am J Physiol Heart Circ Physiol 301: H1341-H1352.
    • Ren Y, Garvin JL, Carretero OA (2002). Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 39: 799-802.
    • Ridker PM, Luscher TF (2014). Anti-inflammatory therapies for cardiovascular disease. Eur Heart J 35: 1782-1791.
    • Rodrigues-Machado MG, Magalhaes GS, Cardoso JA, Kangussu LM, Murari A, Caliari MV et al. (2013). AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma. Br J Pharmacol 170: 835-846.
    • Rubio-Ruiz ME, Del Valle-Mondragon L, Castrejon-Tellez V, CarreonTorres E, Diaz-Diaz E, Guarner-Lans V (2014). Angiotensin II and 1-7 during aging in Metabolic Syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue. Peptides 57: 101-108.
    • Sagan A, Mrowiecki W, Mikolajczyk TP, Urbanski K, Siedlinski M, Nosalski R et al. (2012). Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms. Relationship to clinical risk factors. Thromb Haemost 108: 812-823.
    • Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM (2006). Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49: 185-192.
    • Santos RAS, Simoes e Silva AC, Maric C, Silva DMR, Machado RP, de Buhr I et al. (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci 100: 8258-8263.
    • Silveira KD, Barroso LC, Vieira AT, Cisalpino D, Lima CX, Bader M et al. (2013). Beneficial effects of the activation of the angiotensin-(1- 7) MAS receptor in a murine model of adriamycin-induced nephropathy. PLoS One 8: e66082.
    • Simoes e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM (2013). ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.
    • Br J Pharmacol 169: 477-492.
    • Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH et al. (2016). The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44 (Database Issue): D1054-D1068.
    • (2016). Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE / mice.
    • Arterioscler Thromb Vasc Biol 36: 1174-1185.
    • Suski M, Olszanecki R, Stachowicz A, Madej J, Bujak-Gizycka B, Okon K et al. (2013). The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice. Biochim Biophys Acta 1834: 2463-2469.
    • Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE (2010).
    • Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 30: 1606-1613.
    • (2010). Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122: 2529-2537.
    • Vu DM, Tai A, Tatro JB, Karas RH, Huber BT, Beasley D (2014).
    • gammadeltaT cells are prevalent in the proximal aorta and drive http://doi.org/10.1111/bph.13685
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Funded by projects

  • WT

Cite this article